Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Vetter Continues to Strengthen its Market Position

Published: Wednesday, January 15, 2014
Last Updated: Wednesday, January 15, 2014
Bookmark and Share
Another positive year for the CDMO.

Vetter has announced that 2013 was yet another growth year for the company. As evidenced by a growing demand for customer projects in clinical phases and commercial aseptic manufacturing, the CDMO increased sales by more than 10 percent.

Currently the company employs around 3,300 people at its German and US facilities. This sustained, positive development by the company was made possible as a result of its high quality and safety standards, as well as investments made across the company’s facilities for process optimization.

With an increase in market demand, Vetter responded by strengthening and reinforcing its position as a strategic partner for both the development phase, and commercial manufacturing of parenteral drugs.

These actions included the increase in its capacities and service portfolio in production sites in Germany and the US. The company is planning the implementation of three new filling lines and is also making investments in innovative technologies.

Vetter will also continue to optimize its quality management and processes in manufacturing and logistics to support pharmaceutical and biotech companies in meeting market requirements of quality and safety.

Still another reason for the strong growth is the newly launched customer projects at Vetter’s Chicago site. Here the company supports its customers in process development and manufacturing of clinical trials during product development.

Once the clinical development phases are completed, the product it transferred to the German facilities for commercial production and market supply.

"Increasingly, our customers rely on our expertise and more than thirty-five years of experience in aseptic filling of injection systems," said Vetter Managing Director Peter Soelkner. “Next to a reliable production for continuous market supply, we also supported our customers with their complex development projects with our Development Service both in Chicago and Ravensburg."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Creation of a New 70 Million Euro Vetter Production Building
Company has announced that the new construction at a ground breaking ceremony represents an important component of a previously announced investment strategy.
Wednesday, March 23, 2016
Leading CDMO is Granted Both the Worldstar Award for Vetter-Ject® and a 2016 CMO Leadership Award
Company has announced that the worldStar competition is one of the major events of the WPO, and its award represents the pre-eminent international award in packaging.
Friday, February 19, 2016
Vetter Announces Completion of its Schuetzenstrasse Multi-Functional Building
2015 developments reflect another positive year of growth for the pharmaceutical service provider.
Sunday, January 31, 2016
Vetter Receives Internationally Recognized AEO-F Certificate
Pharmaceutical service providers and customers benefit from comprehensive tariff advantages.
Wednesday, December 02, 2015
Vetter Announces Office Opening in Japan
Company’s second office in the region will strengthen customer relations and help develop new business among emerging and established Japanese companies.
Thursday, October 15, 2015
Vetter Embarks on a 300 Million Euro Investment Strategy
Company will invest for further development to its manufacturing sites and to make available additional manufacturing capacities.
Thursday, October 01, 2015
Vetter Development Service Chicago Completes Recent On-Site Expansion Activities
Continued demand and increased customer product transfers are generating a positive business outlook for the company’s early-stage development facility.
Thursday, June 11, 2015
Vetter Serializes the First Product for South Korea
CDMO produces clearly identifiable labelling for a top-ten pharmaceutical company.
Saturday, May 02, 2015
Vetter Appoints Oliver Albrecht as Managing Director
Role with company commenced on April 1, 2015.
Thursday, April 09, 2015
Vetter Continues to Expand Capacity
Structural work completed on Vetter’s new multi-functional building for its Development Service and information technology (IT).
Friday, January 30, 2015
Vetter Adds Flexible Serialization Service to its Portfolio
A new service allowing for the explicit identification of drug packaging.
Thursday, December 04, 2014
Vetter Announces Opening of Office to Support Growing Asian Healthcare Market
New Asia Pacific office will support customer relations and the development of new business.
Friday, November 21, 2014
Vetter Announces Personnel Changes in its Development Service Division
Clinical manufacturing services continue to attract new business.
Saturday, October 18, 2014
Vetter to Construct New Filling Lines to Expand Capacity
Responding to customer demand and company growth.
Thursday, October 10, 2013
Vetter’s New Commercial Filling Line Ready for cGMP Filling
Novel, high-tech line fully validated; first customer project underway.
Monday, April 08, 2013
Scientific News
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Bioreactors Ready for the Big Time
Bioreactors are passive filtration systems that can reduce nitrate losses from farm fields.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!